Prevalence and associated factors of chemotherapy‐related cognitive impairment in older breast cancer survivors
Prevalence and associated factors of chemotherapy‐related cognitive impairment in older breast cancer survivors is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Prevalence and associated factors of chemotherapy‐related cognitive impairment in older breast cancer survivors have?
Prevalence and associated factors of chemotherapy‐related cognitive impairment in older breast cancer survivors has 22 citations in the OpenAlex counts ScholarIQ stores.
When was Prevalence and associated factors of chemotherapy‐related cognitive impairment in older breast cancer survivors published?
Prevalence and associated factors of chemotherapy‐related cognitive impairment in older breast cancer survivors has 2023 year in the ScholarIQ index.
What is the open-access status of Prevalence and associated factors of chemotherapy‐related cognitive impairment in older breast cancer survivors?
Prevalence and associated factors of chemotherapy‐related cognitive impairment in older breast cancer survivors has closed oa status in the ScholarIQ index.
What is the DOI of Prevalence and associated factors of chemotherapy‐related cognitive impairment in older breast cancer survivors?
The DOI for Prevalence and associated factors of chemotherapy‐related cognitive impairment in older breast cancer survivors is on the source record.
What is the PMID of Prevalence and associated factors of chemotherapy‐related cognitive impairment in older breast cancer survivors?
The PMID for Prevalence and associated factors of chemotherapy‐related cognitive impairment in older breast cancer survivors is on the source record.
What is the OpenAlex record for Prevalence and associated factors of chemotherapy‐related cognitive impairment in older breast cancer survivors?
The OpenAlex for Prevalence and associated factors of chemotherapy‐related cognitive impairment in older breast cancer survivors is on the source record.